The US Meals and Drug Administration defended the federal government’s latest selection to extend out its limited source of the Jynneos monkeypox vaccine by providing persons smaller doses applying a distinct technique of injection, pointing out in a letter to the enterprise that manufactures the vaccine that a 2015 clinical analyze confirmed “a quite related immune response” to the new process as properly as the earlier applied 1.